SYTL4: A Potential Drug Target and Biomarker for Various Diseases

Target Name: SYTL4

NCBI ID: G94121

SYTL4

SYTL4: A Potential Drug Target and Biomarker for Various Diseases

Syntax: The protein SYTL4, also known as exophilin-2, plays a crucial role in the structure and function of the cell membrane. Its unique structure and multiple functions make it an attractive drug target and a potential biomarker for various diseases.

Introduction:
SYTL4, also known as exophilin-2, is a protein that belongs to the family of cytoskeletal proteins, which are responsible for maintaining the structural integrity of the cell membrane. It is highly conserved across various species, including humans, and has been identified as a potential drug target and biomarker for various diseases.

Structure and function:
SYTL4 is a 21-kDa protein that consists of 105 amino acid residues. It has a unique structure, with a long amino acid tail that is rich in negatively charged residues. This feature is known as an exophilin, which is a protein that is rich in negatively charged residues that can interact with other negatively charged molecules.

The exophilin region of SYTL4 is responsible for its unique structure and function. It plays a critical role in the regulation of cell adhesion, as well as the regulation of the cytoskeleton. Additionally, it is involved in the formation of tight junctions, which are a type of cell-cell barrier that helps to maintain the integrity of the cell membrane.

SYTL4 is also involved in the regulation of the actin cytoskeleton. It plays a critical role in the regulation of the actin filament, which is responsible for the cytoskeleton. The cytoskeleton is responsible for the maintenance of the cell shape and helps to regulate various cellular processes.

Drug targeting:
SYTL4 is an attractive drug target due to its unique structure and multiple functions. Its exophilin region and cytoskeleton-related functions make it an excellent candidate for small molecules that can modulate its activity.

One of the potential drug targets for SYTL4 is the regulation of cell adhesion. Disruptions in cell-cell adhesion have been linked to various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. Therefore, small molecules that can modulate SYTL4 activity and regulate cell-cell adhesion may be an attractive drug target for the treatment of these diseases.

Another potential drug target for SYTL4 is the regulation of the cytoskeleton. Disruptions in cytoskeleton-related functions have been linked to various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. Therefore, small molecules that can modulate SYTL4 activity and regulate cytoskeleton-related functions may be an attractive drug target for the treatment of these diseases.

Biomarker:
SYTL4 has also been identified as a potential biomarker for various diseases. Its unique structure and multiple functions make it an excellent candidate for diagnostic tools.

One of the potential applications of SYTL4 as a biomarker is its ability to interact with certain proteins, including the protein known as FAK. SYTL4 has been shown to interact with FAK and regulate its activity. Therefore, small molecules that can modulate SYTL4 activity and interact with FAK may be an attractive biomarker for the diagnosis of certain diseases.

Conclusion:
SYTL4 is a protein that plays a crucial role in the structure and function of the cell membrane. Its unique structure and multiple functions make it an attractive drug target and a potential biomarker for various diseases. The regulation of cell adhesion and the cytoskeleton, as well as the regulation of actin cytoskeleton, are some of the key functions of SYTL4. Therefore, small molecules that can modulate SYTL4 activity and regulate cell-cell adhesion, cytoskeleton-related functions, and actin cytoskeleton may be an attractive drug targets for the treatment of various diseases. Additionally, its unique structure and multiple functions make it an excellent candidate for diagnostic tools.

Protein Name: Synaptotagmin Like 4

Functions: Modulates exocytosis of dense-core granules and secretion of hormones in the pancreas and the pituitary. Interacts with vesicles containing negatively charged phospholipids in a Ca(2+)-independent manner (By similarity)

The "SYTL4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SYTL4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets